We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

19 hedge funds and large institutions have $2.75M invested in Minerva Neurosciences in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

5.6% less ownership

Funds ownership: 38% → 32.39% (-5.6%)

24% less funds holding

Funds holding: 25 → 19 (-6)

57% less call options, than puts

Call options by funds: $37K | Put options by funds: $87K

75% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 8

85% less capital invested

Capital invested by funds: $18.6M → $2.75M (-$15.9M)

Holders
19
Holders Change
-6
Holders Change %
-24%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
4
Closed
8
Calls
$37K
Puts
$87K
Net Calls
-$50K
Net Calls Change
+$243K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$131K
2
Renaissance Technologies
Renaissance Technologies
New York
+$36.7K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$5.3K
4
BlackRock
BlackRock
New York
+$3.22K
5
Millennium Management
Millennium Management
New York
+$1.39K

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$2.31M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$261K
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$231K
4
Truist Financial
Truist Financial
North Carolina
-$102K
5
UBS Group
UBS Group
Switzerland
-$53K
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$1.91M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$308K +$131K +30,344 +19%
Renaissance Technologies
3
Renaissance Technologies
New York
$175K +$36.7K +8,500 +8%
BlackRock
4
BlackRock
New York
$125K +$3.22K +745 +1%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$65K +$5.3K +1,227 +3%
Millennium Management
6
Millennium Management
New York
$46K +$1.39K +321 +1%
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$44K -$6.02K -1,393 -5%
BCM
8
Bridgeway Capital Management
Texas
$24.5K -$3.08K -712 -4%
State Street
9
State Street
Massachusetts
$21.8K – – –
Morgan Stanley
10
Morgan Stanley
New York
$13.8K -$21.4K -4,944 -36%
Group One Trading
11
Group One Trading
Illinois
$9.2K -$208 -48 -0.8%
Wells Fargo
12
Wells Fargo
California
$3.14K +$4 +1 +0.1%
Russell Investments Group
13
Russell Investments Group
United Kingdom
$1.87K – – –
TFM
14
TFC Financial Management
Massachusetts
$296 – – –
Northwestern Mutual Wealth Management
15
Northwestern Mutual Wealth Management
Wisconsin
$159 – – –
BAM
16
Belpointe Asset Management
Nevada
$159 +$432 +100 New
AIM
17
Anchor Investment Management
South Carolina
$19 – – –
Bank of America
18
Bank of America
North Carolina
$10 +$26 +6 New
AG
19
Artal Group
Luxembourg
– -$2.31M -250,000 Closed
Fidelity Investments
20
Fidelity Investments
Massachusetts
– -$261K -28,272 Closed
Point72 Asset Management
21
Point72 Asset Management
Connecticut
– -$231K -25,000 Closed
Truist Financial
22
Truist Financial
North Carolina
– -$102K -11,043 Closed
Bank of Montreal
23
Bank of Montreal
Ontario, Canada
– -$97 -10,000 Closed
UBS Group
24
UBS Group
Switzerland
– -$53K -5,732 Closed
Lazard Asset Management
25
Lazard Asset Management
New York
– -$19K -2,084 Closed
1
2

NERV Hedge Fund Activity: Q4 2022 in Review

19 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q4 2022, worth a combined $2.75M — down 85% from $18.6M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of NERV and 2 opened new positions — a net loss of 6 holders — while 4 trimmed existing stakes and 6 added.

The largest buyer was Vanguard Group, adding an estimated $131K. The largest seller was Artal Group, exiting entirely with an estimated $2.31M sold.

  • 19 institutional investors held Minerva Neurosciences (NERV) as of Q4 2022, down from 25 in Q3 2022.
  • Funds reported $2.75M of Minerva Neurosciences stock for Q4 2022, down 85% quarter-over-quarter.
  • 2 funds opened new Minerva Neurosciences positions in Q4 2022 and 8 closed out, a net change of -6 holders.
  • The largest Minerva Neurosciences buyer in Q4 2022 was Vanguard Group, an estimated $131K added.
  • The largest Minerva Neurosciences seller in Q4 2022 was Artal Group, an estimated $2.31M sold.

Based on aggregated 13F filings for Q4 2022.